Article
Harnessing PROTAC technology to combat stress hormone receptor activation
2023-03-18
Abstract excerpt
Counteracting the overactivation of glucocorticoid receptors (GR) is an important therapeutic goal in stress-related psychiatry and beyond. The only clinically approved GR antagonist lacks selectivity and induces unwanted side effects. To complement existing tools of small-molecule-based inhibitors, we present a highly potent, novel catalytically-driven GR degrader, KH-103, based on proteolysis-targeting chimera t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3c7a6daa-01fe-54c4-88ce-4696c1e0de46
- DOI
- 10.1101/2023.03.17.533120
